We have observed
20 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 09, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMPOUNDS BINDING TO THE BACTERIAL BETA RING
LACTOBACILLUS PARACASEI SUBSP. PARACASEI, AS AN AGENT FOR INHIBITING LISTERIA MONOCYTOGENES IN VIVO INFECTION
NOVEL STRAIN OF LACTOBACILLUS MUCOSAE
Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
METHOD FOR QUANTIFYING DIFFERENT VIRAL FORMS OF THE DNA OF THE HIV VIRUS
USE OF A WARMER FOR PROMOTING A BIOLOGICAL REACTION
USE OF NANODIAMONDS FOR GENERATING FREE RADICALS FOR THERAPEUTIC PURPOSES UNDER RADIATION
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
CELL-FREE DNA AS A THERAPEUTIC TARGET FOR FEMALE INFERTILITY AND DIAGNOSTIC MARKER
Method for emulsifying a triepitope peptide with montanide and kits for performing the same
Method and device for conserving viable and functional human polymorphonuclear neutrophils
USE OF LACTOBACILLUS RHAMNOSUS STRAIN FOR REDUCING WEIGHT GAIN AND/OR INSULIN RESISTANCE
LACTOBACILLUS RHAMNOSUS STRAIN FOR REDUCING BODY FAT ACCUMULATION
CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES
Use of immune combinatorial diversity as a predictive marker for identifying patients likely to respond to an anti-CTLA-4 treatment
Green microalgae lacking a functional DYRKP-1 gene, for use for increased production of feedstock
NON-INVASIVE METHOD FOR MEASURING TISSUE PERFUSION STATE